Heart disease is a global health problem with no geographic, gender, or socio-economic boundaries. Despite the tremendous advances in cardiac care have been made recently, including drugs, devices, and diagnostic innovation, many patients continue to die from heart disease or live with significant morbidity. Challenges for the next decade include health promotion and disease prevention, obesity and diabetes, and acute heart failure and cardiorenal disease. We must broaden our scope of intervention to emphasize and extend preventive strategies, and translate our innovations into actions through carefully designed health policy strategies. Genomic and proteomic biomarkers promise to improve early detection and risk stratification, leading to a more personalized approach to cardiovascular medicine.
This conference brings together the most exciting advances in heart failure and related cardiometabolic medicine, from treatment to prevention, and innovation to application. The program is unique because of its translational theme. The global faculty and participating audience present the faces of cardiovascular medicine with a truly international perspective.
To enhance the learning experience, the meeting features lectures, problem-solving sessions and case presentations to foster interaction between the faculty and the participants. The workshops will be particularly valuable in translating theoretical concepts and guidelines to individual cases in practice.
Upon completion of this program attendees should be able to:
Choose effective imaging strategies for the assessment of ischemic disease and heart failure
Implement preventative cardiology recommendations and advocate health promotion
Review the latest guidelines and surrogate marker targets for diabetic heart disease
Better understand the pathophysiology and management of cardiorenal disease
Implement the latest rhythm and device strategies
Review the advances in genomic medicine and understand its applications
Recognize the importance of socioeconomic determinants of cardiovascular health
Address the difficult choices involved in caring for a patient with advanced heart failure
Who should Attend
Cardiologists, Internists & Primary Care Physicians
Cardiovascular Surgeons
Allied Health Professionals (ACNP, Nurses, Pharmacists)
Heart Failure Care Teams
Trainees
Clinical Researchers
Research Scientists
Program Directors
Peter P. Liu, MD, FRCP(C), FACC
Scientific Director, Institute of Circulatory and Respiratory Health
Associate Professor, Dept. of Medicine, University of Toronto
Staff Cardiologist, Toronto General Hospital
Akira Matsumori, MD, PhD, FACC, FAHA, FESC
Secretary of the World Heart Federation
Kyoto University, Japan
Gary E. Newton, MD, FRCP(C)
Head, Division of Cardiology
University Health Network and Mount Sinai Hospital
Pfizer Chair in Cardiovascular Research
Associate Professor, Deptartment of Medicine, University of Toronto
